SCHEMBL6312657

SCHEMBL6312657

CCCCc1c(C)c(C#N)c2nc3c(C)cccc3n2c1N1CC[C@H](N(C)C)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 5/20 0.44
KMT2A Q03164 3/20 0.44
HPGD P15428 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
MAPT P10636 2/20 0.44
RAB9A P51151 2/20 0.44
HTT P42858 1/20 0.44
HIF1A Q16665 1/20 0.43
MEN1 O00255 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ALDH1A1 P00352 7/20 0.41
TSHR P16473 3/20 0.41
HSD17B10 Q99714 2/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 1/20 0.40
SLC2A1 P11166 1/20 0.38
KDM4E B2RXH2 4/20 0.38
GLA P06280 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6310356 0.86 L3MBTL1 (0.46) NPSR1KMT2AHPGDSMN1; SMN2MAPT
SCHEMBL6312844 0.85 L3MBTL1 (0.59) NPSR1KMT2AHPGDSMN1; SMN2MAPT
SCHEMBL6319981 0.84 NPSR1 (0.43) NPSR1KMT2AHPGDSMN1; SMN2MAPT
SCHEMBL6312655 0.84 NPSR1 (0.44) NPSR1KMT2AHPGDSMN1; SMN2MAPT
Formic Acid SCHEMBL6313188 0.84 NPSR1 (0.54) NPSR1KMT2AHPGDSMN1; SMN2MAPT
SCHEMBL6311719 0.81 NPSR1 (0.46) NPSR1KMT2AHPGDSMN1; SMN2MAPT
SCHEMBL6311130 0.80 HIF1A (0.57) NPSR1KMT2AHPGDSMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL6311165 0.80 HIF1A (0.55) NPSR1KMT2AHPGDSMN1; SMN2MAPT
SCHEMBL6312291 0.79 KMT2A (0.49) NPSR1KMT2AHPGDSMN1; SMN2MAPT
SCHEMBL6311707 0.77 HPGD (0.45) NPSR1KMT2AHPGDSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-05-26 US disclosed
EP-1479681-A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative MANBA, MAN2B1, ERG28 NPSR1 1531/4885KMT2A 4210/4885HPGD 2061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.